{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:23:23Z","timestamp":1772108603148,"version":"3.50.1"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100007515","name":"National Natural Youth Science Foundation","doi-asserted-by":"crossref","award":["No.8220154434"],"award-info":[{"award-number":["No.8220154434"]}],"id":[{"id":"10.13039\/100007515","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100019091","name":"Key Research and Development Program of Hunan Province of China","doi-asserted-by":"publisher","award":["2023SK2057"],"award-info":[{"award-number":["2023SK2057"]}],"id":[{"id":"10.13039\/501100019091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-01784-0","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T08:52:55Z","timestamp":1736931175000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Exploring the mechanism of rosmarinic acid in the treatment of lung adenocarcinoma based on bioinformatics methods and experimental validation"],"prefix":"10.1007","volume":"16","author":[{"given":"Chaowang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruqian","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijun","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianzhong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoning","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengzhou","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoyu","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuomei","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"1784_CR1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin."},{"key":"1784_CR2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1916623","author":"N Howlader","year":"2020","unstructured":"Howlader N, Forjaz G, Mooradian MJ, Meza R, Kong CY, Cronin KA, et al. The effect of advances in lung-cancer treatment on population mortality. N Engl J Med. 2020. https:\/\/doi.org\/10.1056\/NEJMoa1916623.","journal-title":"N Engl J Med"},{"key":"1784_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13164033","author":"D Stefani","year":"2021","unstructured":"Stefani D, Pl\u00f6nes T, Viehof J, Darwiche K, Stuschke M, Schuler M, et al. Lung cancer surgery after neoadjuvant immunotherapy. Cancers. 2021. https:\/\/doi.org\/10.3390\/cancers13164033.","journal-title":"Cancers"},{"key":"1784_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23137222","author":"M de Scordilli","year":"2022","unstructured":"de Scordilli M, Michelotti A, Bertoli E, De Carlo E, Del Conte A, Bearz A. Targeted therapy and immunotherapy in early-stage non-small cell lung cancer: current evidence and ongoing trials. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23137222.","journal-title":"Int J Mol Sci"},{"key":"1784_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2108","author":"Y Xiang","year":"2019","unstructured":"Xiang Y, Guo Z, Zhu P, Chen J, Huang Y. Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science. Cancer Med. 2019. https:\/\/doi.org\/10.1002\/cam4.2108.","journal-title":"Cancer Med"},{"key":"1784_CR6","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2021.01318","author":"X Zhang","year":"2021","unstructured":"Zhang X, Qiu H, Li C, Cai P, Qi F. The positive role of traditional Chinese medicine as an adjunctive therapy for cancer. Biosci Trends. 2021. https:\/\/doi.org\/10.5582\/bst.2021.01318.","journal-title":"Biosci Trends"},{"key":"1784_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111044","author":"K Wang","year":"2021","unstructured":"Wang K, Chen Q, Shao Y, Yin S, Liu C, Liu Y, et al. Anticancer activities of TCM and their active components against tumor metastasis. Biomed Pharmacother. 2021. https:\/\/doi.org\/10.1016\/j.biopha.2020.111044.","journal-title":"Biomed Pharmacother"},{"key":"1784_CR8","doi-asserted-by":"publisher","DOI":"10.1021\/jf010697n","author":"W Zheng","year":"2001","unstructured":"Zheng W, Wang SY. Antioxidant activity and phenolic compounds in selected herbs. J Agric Food Chem. 2001. https:\/\/doi.org\/10.1021\/jf010697n.","journal-title":"J Agric Food Chem"},{"key":"1784_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.phytochem.2009.05.010","author":"M Petersen","year":"2009","unstructured":"Petersen M, Abdullah Y, Benner J, Eberle D, Gehlen K, H\u00fccherig S, et al. Evolution of rosmarinic acid biosynthesis. Phytochemistry. 2009. https:\/\/doi.org\/10.1016\/j.phytochem.2009.05.010.","journal-title":"Phytochemistry"},{"key":"1784_CR10","doi-asserted-by":"publisher","DOI":"10.3109\/07388551.2011.596804","author":"VP Bulgakov","year":"2012","unstructured":"Bulgakov VP, Inyushkina YV, Fedoreyev SA. Rosmarinic acid and its derivatives: biotechnology and applications. Crit Rev Biotechnol. 2012. https:\/\/doi.org\/10.3109\/07388551.2011.596804.","journal-title":"Crit Rev Biotechnol"},{"key":"1784_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114687","author":"S Ijaz","year":"2023","unstructured":"Ijaz S, Iqbal J, Abbasi BA, Ullah Z, Yaseen T, Kanwal S, et al. Rosmarinic acid and its derivatives: current insights on anticancer potential and other biomedical applications. Biomed Pharmacother. 2023. https:\/\/doi.org\/10.1016\/j.biopha.2023.114687.","journal-title":"Biomed Pharmacother"},{"key":"1784_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.6584","author":"XZ Liao","year":"2020","unstructured":"Liao XZ, Gao Y, Sun LL, Liu JH, Chen HR, Yu L, et al. Rosmarinic acid reverses non-small cell lung cancer cisplatin resistance by activating the MAPK signaling pathway. Phytother Res. 2020. https:\/\/doi.org\/10.1002\/ptr.6584.","journal-title":"Phytother Res"},{"key":"1784_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/biom12101410","author":"J Zhao","year":"2022","unstructured":"Zhao J, Xu L, Jin D, Xin Y, Tian L, Wang T, et al. Rosmarinic acid and related dietary supplements: potential applications in the prevention and treatment of cancer. Biomolecules. 2022. https:\/\/doi.org\/10.3390\/biom12101410.","journal-title":"Biomolecules."},{"issue":"12","key":"1784_CR14","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","volume":"1863","author":"M Redza-Dutordoir","year":"2016","unstructured":"Redza-Dutordoir M, Averill-Bates DA. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta. 2016;1863(12):2977\u201392. https:\/\/doi.org\/10.1016\/j.bbamcr.2016.09.012.","journal-title":"Biochim Biophys Acta"},{"key":"1784_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713302","author":"Y Song","year":"2023","unstructured":"Song Y, Kelava L, Kiss I. MiRNAs in lung adenocarcinoma: role, diagnosis, prognosis, and therapy. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241713302.","journal-title":"Int J Mol Sci."},{"issue":"3","key":"1784_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"1784_CR17","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/s41591-021-01450-2","volume":"27","author":"M Wang","year":"2021","unstructured":"Wang M, Herbst RS, Boshoff C. Toward personalized treatment approaches for non-small-cell lung cancer. Nat Med. 2021;27(8):1345\u201356. https:\/\/doi.org\/10.1038\/s41591-021-01450-2.","journal-title":"Nat Med."},{"key":"1784_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13020-019-0270-9","volume":"14","author":"H Luo","year":"2019","unstructured":"Luo H, Vong CT, Chen H, Gao Y, Lyu P, Qiu L, et al. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine. Chin Med. 2019;14:48. https:\/\/doi.org\/10.1186\/s13020-019-0270-9.","journal-title":"Chin Med"},{"issue":"24","key":"1784_CR19","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1097\/cm9.0000000000001141","volume":"133","author":"XL Su","year":"2020","unstructured":"Su XL, Wang JW, Che H, Wang CF, Jiang H, Lei X, et al. Clinical application and mechanism of traditional Chinese medicine in treatment of lung cancer. Chin Med J. 2020;133(24):2987\u201397. https:\/\/doi.org\/10.1097\/cm9.0000000000001141.","journal-title":"Chin Med J"},{"key":"1784_CR20","doi-asserted-by":"publisher","first-page":"118281","DOI":"10.1016\/j.jep.2024.118281","volume":"331","author":"J Bai","year":"2024","unstructured":"Bai J, Qin Q, Li S, Cui X, Zhong Y, Yang L, et al. Salvia miltiorrhiza inhibited lung cancer through aerobic glycolysis suppression. J Ethnopharmacol. 2024;331:118281. https:\/\/doi.org\/10.1016\/j.jep.2024.118281.","journal-title":"J Ethnopharmacol"},{"issue":"Pt 2","key":"1784_CR21","doi-asserted-by":"publisher","first-page":"117270","DOI":"10.1016\/j.jep.2023.117270","volume":"319","author":"H Jin","year":"2024","unstructured":"Jin H, Liu C, Liu X, Wang H, Zhang Y, Liu Y, et al. Huaier suppresses cisplatin resistance in non-small cell lung cancer by inhibiting the JNK\/JUN\/IL-8 signaling pathway. J Ethnopharmacol. 2024;319(Pt 2):117270. https:\/\/doi.org\/10.1016\/j.jep.2023.117270.","journal-title":"J Ethnopharmacol"},{"key":"1784_CR22","doi-asserted-by":"publisher","first-page":"155135","DOI":"10.1016\/j.phymed.2023.155135","volume":"122","author":"R Yang","year":"2024","unstructured":"Yang R, Gao W, Wang Z, Jian H, Peng L, Yu X, et al. Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2\/HO-1\/GPX4 axis. Phytomedicine. 2024;122:155135. https:\/\/doi.org\/10.1016\/j.phymed.2023.155135.","journal-title":"Phytomedicine"},{"issue":"1","key":"1784_CR23","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s12672-024-01045-6","volume":"15","author":"P Zhao","year":"2024","unstructured":"Zhao P, He XB, Chen XY, Li ZL, Xing WJ, Liu W, et al. Celastrol inhibits mouse B16\u2013F10 melanoma cell survival by regulating the PI3K\/AKT\/mTOR signaling pathway and repressing HIF-1\u03b1 expression. Discov Oncol. 2024;15(1):178. https:\/\/doi.org\/10.1007\/s12672-024-01045-6.","journal-title":"Discov Oncol"},{"issue":"1","key":"1784_CR24","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s12672-024-01076-z","volume":"15","author":"H Gui","year":"2024","unstructured":"Gui H, Fan X. Anti-tumor effect of dandelion flavone on multiple myeloma cells and its mechanism. Discov Oncol. 2024;15(1):215. https:\/\/doi.org\/10.1007\/s12672-024-01076-z.","journal-title":"Discov Oncol"},{"issue":"4","key":"1784_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s12272-022-01378-2","volume":"45","author":"S Noor","year":"2022","unstructured":"Noor S, Mohammad T, Rub MA, Raza A, Azum N, Yadav DK, et al. Biomedical features and therapeutic potential of rosmarinic acid. Arch Pharm Res. 2022;45(4):205\u201328. https:\/\/doi.org\/10.1007\/s12272-022-01378-2.","journal-title":"Arch Pharm Res"},{"key":"1784_CR26","doi-asserted-by":"publisher","first-page":"109443","DOI":"10.1016\/j.biopha.2019.109443","volume":"120","author":"L Wang","year":"2019","unstructured":"Wang L, Yang H, Wang C, Shi X, Li K. Rosmarinic acid inhibits proliferation and invasion of hepatocellular carcinoma cells SMMC 7721 via PI3K\/AKT\/mTOR signal pathway. Biomed Pharmacother. 2019;120:109443. https:\/\/doi.org\/10.1016\/j.biopha.2019.109443.","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"1784_CR27","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.31557\/apjcp.2021.22.5.1623","volume":"22","author":"Y An","year":"2021","unstructured":"An Y, Zhao J, Zhang Y, Wu W, Hu J, Hao H, et al. Rosmarinic acid induces proliferation suppression of hepatoma cells associated with NF-\u03baB signaling pathway. Asian Pac J Cancer Prev. 2021;22(5):1623\u201332. https:\/\/doi.org\/10.31557\/apjcp.2021.22.5.1623.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1784_CR28","doi-asserted-by":"publisher","first-page":"153861","DOI":"10.1016\/j.phymed.2021.153861","volume":"95","author":"X Zhou","year":"2022","unstructured":"Zhou X, Wang W, Li Z, Chen L, Wen C, Ruan Q, et al. Rosmarinic acid decreases the malignancy of pancreatic cancer through inhibiting Gli1 signaling. Phytomedicine. 2022;95:153861. https:\/\/doi.org\/10.1016\/j.phymed.2021.153861.","journal-title":"Phytomedicine"},{"key":"1784_CR29","doi-asserted-by":"publisher","first-page":"173419","DOI":"10.1016\/j.ejphar.2020.173419","volume":"885","author":"SS Messeha","year":"2020","unstructured":"Messeha SS, Zarmouh NO, Asiri A, Soliman KFA. Rosmarinic acid-induced apoptosis and cell cycle arrest in triple-negative breast cancer cells. Eur J Pharmacol. 2020;885:173419. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173419.","journal-title":"Eur J Pharmacol"},{"key":"1784_CR30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fphar.2018.00068","volume":"9","author":"YH Han","year":"2018","unstructured":"Han YH, Kee JY, Hong SH. Rosmarinic acid activates AMPK to inhibit metastasis of colorectal cancer. Front Pharmacol. 2018;9:68. https:\/\/doi.org\/10.3389\/fphar.2018.00068.","journal-title":"Front Pharmacol."},{"key":"1784_CR31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.12659\/msmbr.913331","volume":"25","author":"W Li","year":"2019","unstructured":"Li W, Li Q, Wei L, Pan X, Huang D, Gan J, et al. Rosmarinic acid analogue-11 induces apoptosis of human gastric cancer SGC-7901 cells via the epidermal growth factor receptor (EGFR)\/Akt\/nuclear factor kappa B (NF-\u03baB) pathway. Med Sci Monit Basic Res. 2019;25:63\u201375. https:\/\/doi.org\/10.12659\/msmbr.913331.","journal-title":"Med Sci Monit Basic Res."},{"key":"1784_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10585-019-09966-1","volume":"3","author":"JA Eble","year":"2019","unstructured":"Eble JA, Niland S. The extracellular matrix in tumor progression and metastasis. Clin Exp Metastasis. 2019;3:171\u201398. https:\/\/doi.org\/10.1007\/s10585-019-09966-1.","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"1784_CR33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-022-01252-0","volume":"15","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Zhang H, Wang J, Liu Y, Luo T, Hua H. Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy. J Hematol Oncol. 2022;15(1):34. https:\/\/doi.org\/10.1186\/s13045-022-01252-0.","journal-title":"J Hematol Oncol"},{"issue":"9","key":"1784_CR34","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1158\/0008-5472.Can-22-2034","volume":"83","author":"D De Martino","year":"2023","unstructured":"De Martino D, Bravo-Cordero JJ. Collagens in cancer: structural regulators and guardians of cancer progression. Cancer Res. 2023;83(9):1386\u201392. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-2034.","journal-title":"Cancer Res"},{"key":"1784_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071780","author":"D De Felice","year":"2020","unstructured":"De Felice D, Alaimo A. Mechanosensitive piezo channels in cancer: focus on altered calcium signaling in cancer cells and in tumor progression. Cancers. 2020. https:\/\/doi.org\/10.3390\/cancers12071780.","journal-title":"Cancers"},{"key":"1784_CR36","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.3389\/fonc.2020.01766","volume":"10","author":"AL Parker","year":"2020","unstructured":"Parker AL, Cox TR. The role of the ECM in lung cancer dormancy and outgrowth. Front Oncol. 2020;10:1766. https:\/\/doi.org\/10.3389\/fonc.2020.01766.","journal-title":"Front Oncol"},{"issue":"2","key":"1784_CR37","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.clnu.2023.12.005","volume":"43","author":"Y Li","year":"2024","unstructured":"Li Y, Pan Y, Zhao X, Wu S, Li F, Wang Y, et al. Peroxisome proliferator-activated receptors: a key link between lipid metabolism and cancer progression. Clin Nutr. 2024;43(2):332\u201345. https:\/\/doi.org\/10.1016\/j.clnu.2023.12.005.","journal-title":"Clin Nutr."},{"key":"1784_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/cells9051133","author":"N Wagner","year":"2020","unstructured":"Wagner N, Wagner KD. PPAR beta\/delta and the Hallmarks of Cancer. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9051133.","journal-title":"Cells."},{"key":"1784_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cells11152432","author":"N Wagner","year":"2022","unstructured":"Wagner N, Wagner KD. Peroxisome proliferator-activated receptors and the hallmarks of cancer. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11152432.","journal-title":"Cells"},{"issue":"964","key":"1784_CR40","doi-asserted-by":"publisher","first-page":"176304","DOI":"10.1016\/j.ejphar.2023.176304","volume":"5","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Xiao B, Liu Y, Wu S, Xiang Q, Xiao Y, et al. Roles of PPAR activation in cancer therapeutic resistance: Implications for combination therapy and drug development. Eur J Pharmacol. 2024;5(964):176304. https:\/\/doi.org\/10.1016\/j.ejphar.2023.176304.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"1784_CR41","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.2355\/eurrev_202102_24844","volume":"25","author":"H Zhang","year":"2021","unstructured":"Zhang H, Zhao B, Zhai ZG, Zheng JD, Wang YK, Zhao YY. Expression and clinical significance of MMP-9 and P53 in lung cancer. Eur Rev Med Pharmacol Sci. 2021;25(3):1358\u201365. https:\/\/doi.org\/10.2355\/eurrev_202102_24844.","journal-title":"Eur Rev Med Pharmacol Sci."},{"issue":"4","key":"1784_CR42","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/lbr.0000000000000094","volume":"21","author":"MK El-Badrawy","year":"2014","unstructured":"El-Badrawy MK, Yousef AM, Shaalan D, Elsamanoudy AZ. Matrix metalloproteinase-9 expression in lung cancer patients and its relation to serum mmp-9 activity, pathologic type, and prognosis. J Bronchology Interv Pulmonol. 2014;21(4):327\u201334. https:\/\/doi.org\/10.1097\/lbr.0000000000000094.","journal-title":"J Bronchology Interv Pulmonol."},{"issue":"7","key":"1784_CR43","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/s1995-7645(14)60099-7","volume":"7","author":"DH Zhang","year":"2014","unstructured":"Zhang DH, Zhang LY, Liu DJ, Yang F, Zhao JZ. Expression and significance of MMP-9 and MDM2 in the oncogenesis of lung cancer in rats. Asian Pac J Trop Med. 2014;7(7):585\u20138. https:\/\/doi.org\/10.1016\/s1995-7645(14)60099-7.","journal-title":"Asian Pac J Trop Med"},{"key":"1784_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100933","author":"MMS Balla","year":"2021","unstructured":"Balla MMS, Patwardhan S, Melwani PK, Purwar P, Kumar A, Pramesh CS, et al. Prognosis of metastasis based on age and serum analytes after follow-up of non-metastatic lung cancer patients. Transl Oncol. 2021. https:\/\/doi.org\/10.1016\/j.tranon.2020.100933.","journal-title":"Transl Oncol"},{"issue":"5","key":"1784_CR45","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.prp.2015.11.014","volume":"212","author":"HJ An","year":"2016","unstructured":"An HJ, Lee YJ, Hong SA, Kim JO, Lee KY, Kim YK, et al. The prognostic role of tissue and serum MMP-1 and TIMP-1 expression in patients with non-small cell lung cancer. Pathol Res Pract. 2016;212(5):357\u201364. https:\/\/doi.org\/10.1016\/j.prp.2015.11.014.","journal-title":"Pathol Res Pract"},{"key":"1784_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032382","author":"CH Liu","year":"2023","unstructured":"Liu CH, Di YP. Matrix metallopeptidase-gene signature predicts stage I lung adenocarcinoma survival outcomes. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24032382.","journal-title":"Int J Mol Sci."},{"key":"1784_CR47","doi-asserted-by":"publisher","first-page":"1195426","DOI":"10.3389\/fonc.2023.1195426","volume":"13","author":"C Wei","year":"2023","unstructured":"Wei C. The multifaceted roles of matrix metalloproteinases in lung cancer. Front Oncol. 2023;13:1195426. https:\/\/doi.org\/10.3389\/fonc.2023.1195426.","journal-title":"Front Oncol"},{"key":"1784_CR48","doi-asserted-by":"publisher","first-page":"393","DOI":"10.18632\/oncotarget.28202","volume":"13","author":"AW Pohlman","year":"2022","unstructured":"Pohlman AW, Moudgalya H, Jordano L, Lobato GC, Gerard D, Liptay MJ, et al. The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer. Oncotarget. 2022;13:393\u2013407. https:\/\/doi.org\/10.18632\/oncotarget.28202.","journal-title":"Oncotarget."},{"issue":"5","key":"1784_CR49","doi-asserted-by":"publisher","first-page":"e37041","DOI":"10.1097\/md.0000000000037041","volume":"103","author":"D Fu","year":"2024","unstructured":"Fu D, Hu Z, Ma H, Xiong X, Chen X, Wang J, et al. PLAU and GREM1 are prognostic biomarkers for predicting immune response in lung adenocarcinoma. Medicine. 2024;103(5):e37041. https:\/\/doi.org\/10.1097\/md.0000000000037041.","journal-title":"Medicine"},{"issue":"10","key":"1784_CR50","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41419-024-07074-x","volume":"15","author":"D Zhang","year":"2024","unstructured":"Zhang D, Wang M, Liu G, Li X, Yu W, Hui Z, et al. Novel FABP4(+)C1q(+) macrophages enhance antitumor immunity and associated with response to neoadjuvant pembrolizumab and chemotherapy in NSCLC via AMPK\/JAK\/STAT axis. Cell Death Dis. 2024;15(10):717. https:\/\/doi.org\/10.1038\/s41419-024-07074-x.","journal-title":"Cell Death Dis."},{"key":"1784_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2017.05.023","author":"JN Moloney","year":"2018","unstructured":"Moloney JN, Cotter TG. ROS signalling in the biology of cancer. Semin Cell Dev Biol. 2018. https:\/\/doi.org\/10.1016\/j.semcdb.2017.05.023.","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"1784_CR52","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00204-022-03421-z","volume":"97","author":"HS Tuli","year":"2023","unstructured":"Tuli HS, Kaur J, Vashishth K, Sak K, Sharma U, Choudhary R, et al. Molecular mechanisms behind ROS regulation in cancer: A balancing act between augmented tumorigenesis and cell apoptosis. Arch Toxicol. 2023;97(1):103\u201320. https:\/\/doi.org\/10.1007\/s00204-022-03421-z.","journal-title":"Arch Toxicol"},{"key":"1784_CR53","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15068","author":"H Nakamura","year":"2021","unstructured":"Nakamura H, Takada K. Reactive oxygen species in cancer: current findings and future directions. Cancer Sci. 2021. https:\/\/doi.org\/10.1111\/cas.15068.","journal-title":"Cancer Sci"},{"issue":"3","key":"1784_CR54","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.7150\/ijbs.85443","volume":"20","author":"TM Chang","year":"2024","unstructured":"Chang TM, Chi MC, Chiang YC, Lin CM, Fang ML, Lee CW, et al. Promotion of ROS-mediated apoptosis, G2\/M arrest, and autophagy by naringenin in non-small cell lung cancer. Int J Biol Sci. 2024;20(3):1093\u2013109. https:\/\/doi.org\/10.7150\/ijbs.85443.","journal-title":"Int J Biol Sci"},{"key":"1784_CR55","doi-asserted-by":"publisher","first-page":"153786","DOI":"10.1016\/j.phymed.2021.153786","volume":"95","author":"FY Zhang","year":"2022","unstructured":"Zhang FY, Li RZ, Xu C, Fan XX, Li JX, Meng WY, et al. Emodin induces apoptosis and suppresses non-small-cell lung cancer growth via downregulation of sPLA2-IIa. Phytomedicine. 2022;95:153786. https:\/\/doi.org\/10.1016\/j.phymed.2021.153786.","journal-title":"Phytomedicine"},{"key":"1784_CR56","doi-asserted-by":"publisher","first-page":"112260","DOI":"10.1016\/j.ejmech.2020.112260","volume":"194","author":"S Mondal","year":"2020","unstructured":"Mondal S, Adhikari N, Banerjee S, Amin SA, Jha T. Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: a minireview. Eur J Med Chem. 2020;194:112260. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112260.","journal-title":"Eur J Med Chem"},{"issue":"3","key":"1784_CR57","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1124\/pharmrev.121.000349","volume":"74","author":"LGN de Almeida","year":"2022","unstructured":"de Almeida LGN, Thode H, Eslambolchi Y, Chopra S, Young D, Gill S, et al. Matrix metalloproteinases: from molecular mechanisms to physiology, pathophysiology, and pharmacology. Pharmacol Rev. 2022;74(3):712\u201368. https:\/\/doi.org\/10.1124\/pharmrev.121.000349.","journal-title":"Pharmacol Rev"},{"issue":"14","key":"1784_CR58","doi-asserted-by":"publisher","first-page":"18458","DOI":"10.18632\/oncotarget.7607","volume":"7","author":"L Gong","year":"2016","unstructured":"Gong L, Wu D, Zou J, Chen J, Chen L, Chen Y, et al. Prognostic impact of serum and tissue MMP-9 in non-small cell lung cancer: a systematic review and meta-analysis. Oncotarget. 2016;7(14):18458\u201368. https:\/\/doi.org\/10.18632\/oncotarget.7607.","journal-title":"Oncotarget"},{"issue":"11","key":"1784_CR59","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.21037\/tcr-22-2246","volume":"11","author":"J Lang","year":"2022","unstructured":"Lang J, Guo Z, Xing S, Sun J, Qiu B, Shu Y, et al. Inhibitory role of puerarin on the A549 lung cancer cell line. Transl Cancer Res. 2022;11(11):4117\u201325. https:\/\/doi.org\/10.21037\/tcr-22-2246.","journal-title":"Transl Cancer Res."},{"issue":"3","key":"1784_CR60","doi-asserted-by":"publisher","first-page":"715","DOI":"10.7150\/ijms.50080","volume":"18","author":"KE Hwang","year":"2021","unstructured":"Hwang KE, Kim HJ, Song IS, Park C, Jung JW, Park DS, et al. Salinomycin suppresses TGF-\u03b21-induced EMT by down-regulating MMP-2 and MMP-9 via the AMPK\/SIRT1 pathway in non-small cell lung cancer. Int J Med Sci. 2021;18(3):715\u201326. https:\/\/doi.org\/10.7150\/ijms.50080.","journal-title":"Int J Med Sci"},{"key":"1784_CR61","doi-asserted-by":"publisher","DOI":"10.1007\/s12038-022-00323-1","author":"X Wang","year":"2023","unstructured":"Wang X, Huang M, Xie W, Ding Q, Wang T. Eupafolin regulates non-small-cell lung cancer cell proliferation, migration, and invasion by suppressing MMP9 and RhoA via FAK\/PI3K\/AKT signaling pathway. J Biosci. 2023. https:\/\/doi.org\/10.1007\/s12038-022-00323-1.","journal-title":"J Biosci"},{"key":"1784_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/cells9051098","author":"YM Chen","year":"2020","unstructured":"Chen YM, Qi S, Perrino S, Hashimoto M, Brodt P. Targeting the IGF-axis for cancer therapy: development and validation of an igf-trap as a potential drug. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9051098.","journal-title":"Cells"},{"key":"1784_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/cells9051261","author":"Q Cai","year":"2020","unstructured":"Cai Q, Dozmorov M, Oh Y. IGFBP-3\/IGFBP-3 receptor system as an anti-tumor and anti-metastatic signaling in cancer. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9051261.","journal-title":"Cells"},{"key":"1784_CR64","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fcell.2020.00286","volume":"8","author":"S Varma Shrivastav","year":"2020","unstructured":"Varma Shrivastav S, Bhardwaj A, Pathak KA, Shrivastav A. Insulin-like growth factor binding protein-3 (IGFBP-3): unraveling the role in mediating IGF-independent effects within the cell. Front Cell Dev Biol. 2020;8:286. https:\/\/doi.org\/10.3389\/fcell.2020.00286.","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"1784_CR65","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.3892\/or.2019.7314","volume":"42","author":"J Wang","year":"2019","unstructured":"Wang J, Hu ZG, Li D, Xu JX, Zeng ZG. Gene expression and prognosis of insulin-like growth factor-binding protein family members in non-small cell lung cancer. Oncol Rep. 2019;42(5):1981\u201395. https:\/\/doi.org\/10.3892\/or.2019.7314.","journal-title":"Oncol Rep"},{"issue":"1","key":"1784_CR66","doi-asserted-by":"publisher","first-page":"T11","DOI":"10.1530\/jme-17-0254","volume":"61","author":"LA Bach","year":"2018","unstructured":"Bach LA. IGF-binding proteins. J Mol Endocrinol. 2018;61(1):T11-t28. https:\/\/doi.org\/10.1530\/jme-17-0254.","journal-title":"J Mol Endocrinol"},{"issue":"25","key":"1784_CR67","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.2174\/1381612828666220608122934","volume":"28","author":"X Xu","year":"2022","unstructured":"Xu X, Qiu Y, Chen S, Wang S, Yang R, Liu B, et al. Different roles of the insulin-like growth factor (IGF) axis in non-small cell lung cancer. Curr Pharm Des. 2022;28(25):2052\u201364. https:\/\/doi.org\/10.2174\/1381612828666220608122934.","journal-title":"Curr Pharm Des"},{"issue":"4","key":"1784_CR68","doi-asserted-by":"publisher","first-page":"321","DOI":"10.14348\/molcells.2019.2441","volume":"42","author":"L Yang","year":"2019","unstructured":"Yang L, Li J, Fu S, Ren P, Tang J, Wang N, et al. Up-regulation of insulin-like growth factor binding protein-3 Is associated with brain metastasis in lung adenocarcinoma. Mol Cells. 2019;42(4):321\u201332. https:\/\/doi.org\/10.14348\/molcells.2019.2441.","journal-title":"Mol Cells."},{"key":"1784_CR69","doi-asserted-by":"publisher","first-page":"654995","DOI":"10.3389\/fonc.2021.654995","volume":"11","author":"Q Luo","year":"2021","unstructured":"Luo Q, Shi W, Dou B, Wang J, Peng W, Liu X, et al. XBP1- IGFBP3 signaling pathway promotes NSCLC Invasion and Metastasis. Front Oncol. 2021;11:654995. https:\/\/doi.org\/10.3389\/fonc.2021.654995.","journal-title":"Front Oncol"},{"issue":"2","key":"1784_CR70","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1631\/jzus.B2000366","volume":"22","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zhang W, Xia M, Xie Z, An F, Zhan Q, et al. High expression of FABP4 in colorectal cancer and its clinical significance. J Zhejiang Univ Sci B. 2021;22(2):136\u201345. https:\/\/doi.org\/10.1631\/jzus.B2000366.","journal-title":"J Zhejiang Univ Sci B."},{"key":"1784_CR71","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.2147\/ott.S311792","volume":"14","author":"Z Wu","year":"2021","unstructured":"Wu Z, Jeong JH, Ren C, Yang L, Ding L, Li F, et al. Fatty acid-binding protein 4 (FABP4) suppresses proliferation and migration of endometrial cancer cells via PI3K\/Akt pathway. Onco Targets Ther. 2021;14:3929\u201342. https:\/\/doi.org\/10.2147\/ott.S311792.","journal-title":"Onco Targets Ther"},{"issue":"6","key":"1784_CR72","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1002\/cam4.1511","volume":"7","author":"CQ Zhong","year":"2018","unstructured":"Zhong CQ, Zhang XP, Ma N, Zhang EB, Li JJ, Jiang YB, et al. FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma. Cancer Med. 2018;7(6):2629\u201340. https:\/\/doi.org\/10.1002\/cam4.1511.","journal-title":"Cancer Med"},{"issue":"4","key":"1784_CR73","doi-asserted-by":"publisher","first-page":"909","DOI":"10.4149\/neo_2022_220107N28","volume":"69","author":"Z Li","year":"2022","unstructured":"Li Z, Yu DP, Wang N, Tao T, Luo W, Chen H. SIRT5 promotes non-small cell lung cancer progression by reducing FABP4 acetylation level. Neoplasma. 2022;69(4):909\u201317. https:\/\/doi.org\/10.4149\/neo_2022_220107N28.","journal-title":"Neoplasma"},{"issue":"62","key":"1784_CR74","doi-asserted-by":"publisher","first-page":"104831","DOI":"10.18632\/oncotarget.21022","volume":"8","author":"YL Hsu","year":"2017","unstructured":"Hsu YL, Hung JY, Lee YL, Chen FW, Chang KF, Chang WA, et al. Identification of novel gene expression signature in lung adenocarcinoma by using next-generation sequencing data and bioinformatics analysis. Oncotarget. 2017;8(62):104831\u201354. https:\/\/doi.org\/10.18632\/oncotarget.21022.","journal-title":"Oncotarget"},{"key":"1784_CR75","doi-asserted-by":"publisher","first-page":"116765","DOI":"10.1016\/j.jep.2023.116765","volume":"317","author":"YM Liu","year":"2023","unstructured":"Liu YM, Li XQ, Zhang XR, Chen YY, Liu YP, Zhang HQ, et al. Uncovering the key pharmacodynamic material basis and possible molecular mechanism of extract of Epimedium against liver cancer through a comprehensive investigation. J Ethnopharmacol. 2023;317:116765. https:\/\/doi.org\/10.1016\/j.jep.2023.116765.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"1784_CR76","doi-asserted-by":"publisher","first-page":"6160","DOI":"10.1038\/s41467-021-26421-6","volume":"12","author":"T Tate","year":"2021","unstructured":"Tate T, Xiang T, Wobker SE, Zhou M, Chen X, Kim H, et al. Pparg signaling controls bladder cancer subtype and immune exclusion. Nat Commun. 2021;12(1):6160. https:\/\/doi.org\/10.1038\/s41467-021-26421-6.","journal-title":"Nat Commun"},{"key":"1784_CR77","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00264.2020","author":"HE Wilson","year":"2021","unstructured":"Wilson HE, Stanton DA, Rellick S, Geldenhuys W, Pistilli EE. Breast cancer-associated skeletal muscle mitochondrial dysfunction and lipid accumulation is reversed by PPARG. Am J Physiol Cell Physiol. 2021. https:\/\/doi.org\/10.1152\/ajpcell.00264.2020.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1784_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-11985-5","author":"L Sch\u00f6ckel","year":"2024","unstructured":"Sch\u00f6ckel L, Woischke C, Surendran SA, Michl M, Schiergens T, H\u00f6lscher A, et al. PPARG activation promotes the proliferation of colorectal cancer cell lines and enhances the antiproliferative effect of 5-fluorouracil. BMC Cancer. 2024. https:\/\/doi.org\/10.1186\/s12885-024-11985-5.","journal-title":"BMC Cancer"},{"issue":"918","key":"1784_CR79","doi-asserted-by":"publisher","first-page":"148474","DOI":"10.1016\/j.gene.2024.148474","volume":"5","author":"L Wang","year":"2024","unstructured":"Wang L, Wang Z, Ni Y, Wang X, Zhang T, Hu M, et al. Elucidating the mechanism of action of Isobavachalcone induced autophagy and apoptosis in non-small cell lung cancer by network pharmacology and experimental validation methods. Gene. 2024;5(918):148474. https:\/\/doi.org\/10.1016\/j.gene.2024.148474.","journal-title":"Gene"},{"issue":"1","key":"1784_CR80","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/1389557521666210422112740","volume":"22","author":"S Yuvaraj","year":"2022","unstructured":"Yuvaraj S, Kumar BRP. Peroxisome proliferator-activated receptor-\u03b3 as a novel and promising target for treating cancer via regulation of inflammation: a brief review. Mini Rev Med Chem. 2022;22(1):3\u201314. https:\/\/doi.org\/10.2174\/1389557521666210422112740.","journal-title":"Mini Rev Med Chem."},{"key":"1784_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115164","author":"X Yang","year":"2023","unstructured":"Yang X, Yang R, Zhang Y, Shi Y, Ma M, Li F, et al. Xianlinglianxiafang Inhibited the growth and metastasis of triple-negative breast cancer via activating PPAR\u03b3\/AMPK signaling pathway. Biomed Pharmacother. 2023. https:\/\/doi.org\/10.1016\/j.biopha.2023.115164.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"1784_CR82","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1021\/acs.jafc.0c06890","volume":"69","author":"Y Liu","year":"2021","unstructured":"Liu Y, Tian Y, Cai W, Guo Y, Xue C, Wang J. DHA\/EPA-enriched phosphatidylcholine suppresses tumor growth and metastasis via activating peroxisome proliferator-activated receptor \u03b3 in lewis lung cancer mice. J Agric Food Chem. 2021;69(2):676\u201385. https:\/\/doi.org\/10.1021\/acs.jafc.0c06890.","journal-title":"J Agric Food Chem."},{"issue":"1\u20132","key":"1784_CR83","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11010-020-03689-8","volume":"466","author":"BK S\u0142owikowski","year":"2020","unstructured":"S\u0142owikowski BK, Drzewiecka H, Malesza M, M\u0105dry I, Sterzy\u0144ska K. The influence of conjugated linoleic acid on the expression of peroxisome proliferator-activated receptor-\u03b3 and selected apoptotic genes in non-small cell lung cancer. Mol Cell Biochem. 2020;466(1\u20132):65\u201382. https:\/\/doi.org\/10.1007\/s11010-020-03689-8.","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"1784_CR84","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.3892\/mmr.2019.10485","volume":"20","author":"LN Ge","year":"2019","unstructured":"Ge LN, Yan L, Li C, Cheng K. Bavachinin exhibits antitumor activity against non-small cell lung cancer by targeting PPAR\u03b3. Mol Med Rep. 2019;20(3):2805\u201311. https:\/\/doi.org\/10.3892\/mmr.2019.10485.","journal-title":"Mol Med Rep"},{"issue":"10","key":"1784_CR85","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/s41419-020-03065-w","volume":"11","author":"TW Kim","year":"2020","unstructured":"Kim TW, Hong DW, Hong SH. CB13, a novel PPAR\u03b3 ligand, overcomes radio-resistance via ROS generation and ER stress in human non-small cell lung cancer. Cell Death Dis. 2020;11(10):848. https:\/\/doi.org\/10.1038\/s41419-020-03065-w.","journal-title":"Cell Death Dis"},{"key":"1784_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10111734","author":"G Muzio","year":"2021","unstructured":"Muzio G, Barrera G, Pizzimenti S. Peroxisome proliferator-activated receptors (PPARs) and oxidative stress in physiological conditions and in cancer. Antioxidants. 2021. https:\/\/doi.org\/10.3390\/antiox10111734.","journal-title":"Antioxidants."},{"key":"1784_CR87","doi-asserted-by":"publisher","first-page":"82491","DOI":"10.18632\/oncotarget.19700","volume":"47","author":"ANH Phan","year":"2017","unstructured":"Phan ANH, Vo VTA, Hua TNM, Kim MK, Jo SY, Choi JW, et al. PPAR\u03b3 sumoylation-mediated lipid accumulation in lung cancer. Oncotarget. 2017;47:82491\u2013505. https:\/\/doi.org\/10.18632\/oncotarget.19700.","journal-title":"Oncotarget."},{"key":"1784_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.02.015","author":"TNM Hua","year":"2019","unstructured":"Hua TNM, Kim MK, Vo VTA, Choi JW, Choi JH, Kim HW, et al. Inhibition of oncogenic Src induces FABP4-mediated lipolysis via PPAR\u03b3 activation exerting cancer growth suppression. EBioMedicine. 2019. https:\/\/doi.org\/10.1016\/j.ebiom.2019.02.015.","journal-title":"EBioMedicine."},{"key":"1784_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101376","author":"M Lamas Bervejillo","year":"2020","unstructured":"Lamas Bervejillo M, Bonanata J, Franchini GR, Richeri A, Marqu\u00e9s JM, Freeman BA, et al. A FABP4-PPAR\u03b3 signaling axis regulates human monocyte responses to electrophilic fatty acid nitroalkenes. Redox Biol. 2020. https:\/\/doi.org\/10.1016\/j.redox.2019.101376.","journal-title":"Redox Biol"},{"key":"1784_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/cells11203215","author":"S Ballav","year":"2022","unstructured":"Ballav S, Biswas B, Sahu VK, Ranjan A, Basu S. PPAR-\u03b3 partial agonists in disease-fate decision with special reference to cancer. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11203215.","journal-title":"Cells."}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-01784-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-01784-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-01784-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T08:52:59Z","timestamp":1736931179000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-01784-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1784"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-01784-0","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"10 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Review Committee of Hunan Provincial Key Laboratory of Traditional Chinese Medicine Diagnostics. All animal experimental procedures were carried out following the Hunan University of Chinese Medicine Animal Experimentation Ethics Guidelines (Approval Number: LL2023051801). This study is reported in accordance with the ARRIVE guidelines, and all subcutaneous tumors in mice were less than 20\u00a0mm in diameter, meeting IRB criteria.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}